drugset / Trial / NCT00666809

Vardenafil in Tinnitus

NCT00666809

Phase 2 Completed 43 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

There is incidental evidence (casuistic findings) that the treatment with vardenafil of male patients suffering from erectile dysfunction and comorbid tinnitus experienced an improvement of their tinnitus. Randomized, parallel-group, double-blind, placebo-controlled trial over 16 weeks (12 weeks of treatment + 4 weeks follow-up) with 10 mg vardenafil BID p.o. in men and women with chronic tinnitus.

Timeline

Start
2006-10
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vardenafil Small molecule 10 mg Oral

Indications